Clinical Trial Update: Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

This Phase 1 study evaluating stereotactic radiosurgery combined with nivolumab and valproate in patients with recurrent glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• VALPROIC ACID (Valproic acid)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Virginia | Conditions: Glioblastoma | Phase 1 | Status: TERMINATED